EOS - Buy Johnson & Johnson For Dividend Growth And Steady Defensive Earnings: Third-Quarter Report
This article is about Johnson & Johnson (JNJ) and why it's a buy for the dividend growth investor and total return investor. Johnson & Johnson is one of the largest manufacturers and distributors of medical products and pharmaceuticals. JNJ is a conservative investment that should be in all portfolios since the company is selling a product that is needed even in a recession. In the 2008-2009 crash, JNJ made a good profit and increased the dividend. The 56th dividend increase in a row was declared in April 2018; an increase from $0.84/Qtr to